Trial site
Hospital General de Segovia
- 15running trials
- 6closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma5 trials
- Type 2 diabetes4 trials
- Acute myeloid leukaemia3 trials
- Asthma2 trials
- Bladder cancer2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Lung cancer2 trials
- Obesity2 trials
- Acute lymphoblastic leukaemia1 trial
- Chronic kidney disease1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- and 3 more
- Phase
- Phase 313 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Completed5 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- PETHEMA Foundation5 trials
- Fundacion PETHEMA4 trials
- Inmunotek S.L.2 trials
- AstraZeneca AB1 trial
- BeOne Medicines1 trial
- and 9 more
Running trials
Recruiting
Not yet recruiting
Clinical trial to assess the efficacy and safety of a vaccine for grass pollen allergy.
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Recruiting
Recruiting
Not yet recruiting
Recruiting
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Recruiting
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism
Recruiting
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Active, not recruiting
Recruiting
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Active, not recruiting
Active, not recruiting
Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Asthma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Bladder cancer1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Obesity1 recruiting
- Prostate cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Terminated
A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026